KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation

Xiangchan Hou(Central South University), Fuyan Wang(W. L. Gore & Associates (Germany)), Le Tang(Central South University), Qijia Yan(Ministry of Health), Qianjin Liao(Central South University), Jiawei Ouyang(Central South University), Songqing Fan(Central South University), Can Guo(Central South University), Guiyuan Li(Central South University), Yong Li(Baylor College of Medicine), Wei Xiong(Central South University), Xiangying Deng(Central South University), Lei Shi(Central South University), Chunmei Fan(Central South University), Pan Wu(Central South University), Zhaoyang Zeng(Central South University)
PLoS Biology
June 21, 2024
10.1371/journal.pbio.3002666
Cited by 76

Related Papers

The cancer metabolic reprogramming and immune response
|Molecular Cancer|2021|1.3k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|390
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|246